
On 3 November, Massachusetts voters decide nine ballot questions. The eighth asks whether the state should repeal the laws that legalised, regulated and taxed adult use cannabis.
No state has ever voted on this. More than twenty states have legalised for adults since 2012 and not one has put repeal to its electorate. Massachusetts will be the first.
The coverage has been loose about what the measure actually does, so here it is properly.
The official ballot title is Prohibit Retail Sale of Adult Recreational Use Marijuana. The petition behind it is called An Act to Restore a Sensible Marijuana Policy.
Legally, it repeals Chapter 94G and Chapter 64N of the Massachusetts General Laws. Those two chapters govern the possession, cultivation, distribution and taxation of cannabis outside the medical programme. They are the foundation the entire licensed market rests on.
A yes vote supports repeal. Per the official summary, it would:
A no vote changes nothing. The current framework stays: licensed retail, home cultivation, the two ounce limit, laboratory testing, labelling rules, age verification, the existing tax structure.
Two points get misreported constantly.
Medical cannabis continues. The programme stays and the Commission keeps regulating it, though the petition language does contemplate new potency limits on medical products.
Possession stays out of the criminal law. Adults twenty one and over could still hold up to one ounce and still gift that amount. What vanishes is anywhere legal to buy it.
The measure sets an effective date of 1 January 2028. A yes vote in November would not close anything overnight. It would start a clock running roughly fourteen months.
That window also leaves room for the Legislature to amend or delay the measure, which it can do with any voter approved statute. Whether it would is a separate question.
Two challenges failed. A lawsuit argued the petition bundled too many unrelated subjects into one question, and the Supreme Judicial Court rejected it. A second challenge disputed the signatures and the tactics used to gather them. The State Ballot Law Commission ruled in July that challengers had not met the burden of proof. Four signatures were disqualified against the 123 that would have been needed to block it, and the Secretary of State was ordered to print the question.
There are no procedural routes left.
The repeal campaign runs as the Coalition for a Healthy Massachusetts. Its money has come largely from Smart Approaches to Marijuana, a Virginia based group led by Kevin Sabet, which filed contributions of 1.55 million dollars in the fourth quarter of 2025 alone. Its spokesperson in Massachusetts is Wendy Wakeman.
Opposition organises under Stop the Repeal, chaired by Ryan Dominguez of the Massachusetts Cannabis Coalition and backed by operators, industry groups and advocacy organisations including NORML.
Three separate polls have asked the question, and the gap between them is worth paying attention to.
The UNH poll surveyed 670 Massachusetts residents including 620 likely voters, and found opposition at 74 percent among Democrats and 69 percent among independents. That poll is now six months old.
The more recent UMass Amherst survey is closer. Repeal still trails by twenty two points and remains the least popular of the nine questions on the ballot, but 33 percent support is a good deal higher than 20.
The Suffolk figure is not directly comparable to either. It surveyed Democratic primary voters specifically, a narrower and more partisan group than the general electorate.
Independents make up roughly two thirds of registered voters in Massachusetts, so where they land matters more than either party. Across all three polls, repeal has not come close to majority support.
The caveat is turnout. This question sits eighth of nine on a long ballot, the voter information booklet runs to around eighty eight pages, and ballots in most communities will be two to three pages. Questions this far down get skipped, and a campaign that is losing on polling can still win on who actually turns up.
Statewide numbers are easy to quote and hard to picture. Locally the effect is simpler to describe.
Southeastern Massachusetts has licensed shops, cultivation sites and testing labs employing people across Bristol and Plymouth counties. A repeal closes the ones serving the adult use market and converts whatever can survive on medical demand alone, which is a much smaller market than it was. Registered patient numbers have fallen from a peak of roughly one hundred thousand to around eighty five thousand.
Municipalities also collect a local option tax of up to three percent on adult use sales, money that goes into town budgets rather than the state. That line disappears with the market.
The less obvious effect is on what people end up buying. Cannabis sold through a licensed shop has been tested for mould, heavy metals and pesticides, labelled with its cannabinoid content and sold only to someone who produced identification.
Commission survey data from 2023 found that respondents obtained an average of 84 percent of their cannabis from legal or authorised sources, up from 56 percent in 2019. Demand does not vanish when the shops close. That share is what moves.
Given the polling, the obvious question is how a measure with twenty percent support got this far.
Massachusetts sets a relatively low bar for initiative petitions compared with the political support needed to actually pass one. A well funded organisation can gather the signatures required without demonstrating anything about public opinion. That is what happened here, and it is why the signature challenge focused on collection tactics rather than the count itself.
It also means the result matters beyond Massachusetts. A repeal campaign losing heavily in a state that legalised early would discourage similar efforts elsewhere. A close result would encourage them.
The Secretary of the Commonwealth publishes the full text, the official summary and the arguments submitted on both sides. That booklet goes to every registered household and it is the authoritative source.
Campaign material on both sides, including anything written by a dispensary, has a position. The official summary does not. Read that one.
In the meantime nothing has changed. All three CANA locations are trading as normal, and current stock is on the Norton, Fairhaven and New Bedford menus.